Comparison
2p21 Microdeletion Syndrome C4304537 vs 13q12 3 Microdeletion Syndrome C4750951
Clinical comparison between 2p21 Microdeletion Syndrome and 13q12 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
2p21 Microdeletion Syndrome C4304537
A rare genetic disorder involving deletion of genetic material on chromosome 2. It may affect multiple body systems and development. Management is tailored to individual symptoms.
13q12 3 Microdeletion Syndrome C4750951
A rare genetic condition where a small piece of chromosome 13 is missing. It can cause various developmental and medical concerns. Care is supportive and tailored to the individual's needs.
6 comparison axes
Onset
2p21 Microdeletion Syndrome C4304537
0-null
13q12 3 Microdeletion Syndrome C4750951
0-null
Onset patterns differ
Severity
2p21 Microdeletion Syndrome C4304537
severe
13q12 3 Microdeletion Syndrome C4750951
moderate
Different severity levels
Chronic
2p21 Microdeletion Syndrome C4304537
Chronic
13q12 3 Microdeletion Syndrome C4750951
Chronic
Differing course
Communicable
2p21 Microdeletion Syndrome C4304537
No
13q12 3 Microdeletion Syndrome C4750951
No
Different transmission
Body System
2p21 Microdeletion Syndrome C4304537
congenital
13q12 3 Microdeletion Syndrome C4750951
congenital
Same/different system
Category
2p21 Microdeletion Syndrome C4304537
rare-disease
13q12 3 Microdeletion Syndrome C4750951
genetic
Different category
Bottom line
2p21-microdeletion-syndrome-C4304537 and 13q12-3-microdeletion-syndrome-C4750951 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p21 Microdeletion Syndrome C4304537 | 13q12 3 Microdeletion Syndrome C4750951 | Discriminating power |
|---|---|---|---|
| Chromosomal locus | Deletion involving chromosome band 2p21 | Microdeletion involving chromosome band 13q12.3 | High |
| Severity classification | Supplied source labels it severe | Supplied source labels it moderate | Moderate |
| Clinical pattern | May affect multiple systems and development; exact features not established | May cause developmental and medical concerns; exact features not established | Low |
When to favor each condition
Choose 2p21 Microdeletion Syndrome C4304537 when
A validated deletion is localized to 2p21
The chromosomal locus directly matches this concept
High
Multisystem congenital findings await genomic confirmation
Findings may be compatible but do not establish the diagnosis
Low
Records use the severe source classification
This reflects supplied labeling, not an independently proven prognosis
Low
Choose 13q12 3 Microdeletion Syndrome C4750951 when
A validated microdeletion is localized to 13q12.3
The chromosomal locus directly matches this concept
High
Developmental concerns occur without a defined syndrome diagnosis
The description is compatible, but testing must confirm the locus
Low
Records use the moderate source classification
This is a supplied severity label and requires clinical interpretation
Low
How key tests differ
| Test | 2p21 Microdeletion Syndrome C4304537 | 13q12 3 Microdeletion Syndrome C4750951 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show copy-number loss at 2p21 | May show copy-number loss at 13q12.3 | The locus distinguishes them; laboratory and clinician confirmation is required |
| Karyotype | May miss a small 2p21 deletion | May miss a small 13q12.3 deletion | A normal karyotype does not exclude either microdeletion |
| Clinical genetics assessment | Correlates examination and history with a 2p21 result | Correlates examination and history with a 13q12.3 result | A test result alone does not define the full phenotype |
Prognosis comparison
2p21 Microdeletion Syndrome C4304537
- Outcome
- Long-term outcome is not established; source severity is severe
- Factors
- Locus, deletion extent, and individual findings may matter
13q12 3 Microdeletion Syndrome C4750951
- Outcome
- Long-term outcome is not established; source severity is moderate
- Factors
- Locus, deletion extent, and individual findings may matter
Time frame: Both are described as chronic congenital conditions; onset details are incomplete
No mortality or universal prognosis can be inferred from the supplied data
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental concerns | Possible, but specific deficits are not established Possible, but specific deficits are not established Individual assessment is required; do not infer a uniform pattern |
| Multisystem medical issues | Source allows multiple-system involvement Source allows varied medical concerns Organ-specific complications are not established from the supplied data |
| Recurrence or transmission | Not communicable; inheritance risk not established here Not communicable; inheritance risk not established here Genetic counseling should interpret family and test data |
Patient education highlights
- HighDiagnosis versus test finding
A chromosomal result requires specialist interpretation and does not by itself describe every health effect.
- HighIndividualized care
Management is supportive and tailored; no standard dose or treatment is established here.
- MediumUncertainty
Ask clinicians which findings are confirmed and which remain uncertain for the individual.